CERVIX CANCER
Clinical trials for CERVIX CANCER explained in plain language.
Never miss a new study
Get alerted when new CERVIX CANCER trials appear
Sign up with your email to follow new studies for CERVIX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster added to standard cervical cancer treatment shows promise in early trial
Disease control TerminatedThis study tested adding the immune-boosting drug pembrolizumab to standard chemoradiation for people with advanced cervical cancer. The goal was to see if the combination is safe and to find the best dose. Only one person was enrolled before the study was stopped early, so resul…
Matched conditions: CERVIX CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug combo for cervical cancer shows early promise, but trial halted
Disease control TerminatedThis early-phase trial tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had spread or returned. Only 5 participants were enrolled before the study was terminated. The goal was to see if…
Matched conditions: CERVIX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Early scan hopes to predict cervical cancer outcomes
Knowledge-focused TerminatedThis study looked at whether MRI and PET scans taken two weeks into radiotherapy can predict if cervical cancer will be controlled. Researchers measured tumor size and activity in 9 patients with stage I to IIIB cervical cancer. The goal was to find early signs of treatment failu…
Matched conditions: CERVIX CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC